Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec, Jain Foundation Extend Research Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec, Jain Foundation Extend Research Pact

Assay and screening capabilities to further muscular dystrophy research

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG and the Jain Foundation have extended and expanded their research collaboration using Evotec’s assay development and screening capabilities to support the Jain Foundation’s research efforts to find a cure for dysferlinopathy. Financial details were not disclosed.
 
Dr. Mario Polywka, chief operating officer of Evotec, said, “We look forward to our continued collaboration with the Jain Foundation on this project. This collaboration highlights both the increasing role that foundations play in delivering solutions for unmet medical needs and also how Evotec’s broad and comprehensive discovery platform can be leveraged in support of these goals in a highly efficient and effective manner.”
 
Dr. Plavi Mittal, president and chief executive officer of the Jain Foundation added, “We are excited to be moving toward screening compound libraries with Evotec. This is an important step toward accomplishing our mission of finding a therapy for Limb-girdle muscular dystrophy type 2B /Miyoshi Myopathy (LGMD2B/MM).”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics